Abstract: Techniques are disclosed relating to performing marine surveys according to dither values generated based on one or more dithering constraints. This may include for example, determining a set of nominal shot points for a marine seismic energy source and determining dither values for ones of the nominal shot points. In some embodiments, the dither values are randomly generated, subject to a duplication constraint such that at most a threshold number of dither differences between consecutive shot points that fall within discrete ranges. In some embodiments, actual shot points are determined for the planned sail line based on application of the determined dither values to the nominal shot points. In various embodiments, the disclosed techniques may facilitate a separate de-blending procedure to separate signals from the marine seismic energy source and signals from one or more other seismic energy sources to be used for the seismic survey.

Abstract: When an electronic ticket is purchased, the ticket is maintained electronically (paperless format) on a consumer-operated device via a ticket wallet application (app). Wallet app obtains ticket details via a scan of an image of the ticket captured from a display of a ticket vendor terminal. Only the wallet app maintains ticket details of the ticket; however, a ticket service cooperates with the wallet app to validate the ticket, to track redemption of the ticket, to authorize printing of the ticket, and to manage the ticket with other tickets of a consumer associated with consumer-operated device.

Abstract: An actuation location for actuation of a first source coupled to a first marine survey vessel relative to a position of a second marine survey vessel towing a receiver to enhance illumination of a subsurface location can be determined based on a survey route of the second marine survey vessel and a priori data of the subsurface location. The first marine survey vessel can be navigated along a survey route of the first marine survey vessel to the actuation location during a marine survey by changing at least a cross-line position or an in-line position of the first marine survey vessel relative to the survey route of the second marine survey vessel.

Abstract: The present disclosure provides methods for prophylactically treating a subject for viral infections comprising topically administering a ranpirnase composition. The disclosure also provides compositions that could be used for prophylactic treatment.

Abstract: The present disclosure provides methods for prophylactically treating a subject for viral infections comprising topically administering a ranpirnase composition. The disclosure also provides compositions that could be used for prophylactic treatment.

Abstract: An actuation location for actuation of a first source coupled to a first marine survey vessel relative to a position of a second marine survey vessel towing a receiver to enhance illumination of a subsurface location can be determined based on a survey route of the second marine survey vessel and a priori data of the subsurface location. The first marine survey vessel can be navigated along a survey route of the first marine survey vessel to the actuation location during a marine survey by changing at least a cross-line position or an in-line position of the first marine survey vessel relative to the survey route of the second marine survey vessel.

Abstract: A method for correction of a sea surface state can include receiving geophysical data from a seismic survey, wherein the seismic survey utilizes a plurality of receivers disposed in a body of water and at least one source in the body of water, actuated at a plurality of shot points. The method can include identifying, in the geophysical data, a wavefield based on the actuation of the at least one source, and determining, based on the identified wavefield, a sea surface state at the at least one source at one of the plurality of shot points.

Abstract: A method of processing BMGs in a non-ideal environment (such as air) to create a uniform and smooth surface is provided. By utilizing the contact-line movement and an engineered flow pattern during TPF the method is able to create complex BMG parts that exhibit uniform smooth appearance or even can be atomically smooth. In addition, to mending surface imperfections, this method also eliminates void formation inside the material, allows for the creation of precise patterns of homogeneous appearance, and forms improved mechanical locks between different materials and a BMG.

Abstract: A method for correction of a sea surface state can include receiving geophysical data from a seismic survey, wherein the seismic survey utilizes a plurality of receivers disposed in a body of water and at least one source in the body of water, actuated at a plurality of shot points. The method can include identifying, in the geophysical data, a wavefield based on the actuation of the at least one source, and determining, based on the identified wavefield, a sea surface state at the at least one source at one of the plurality of shot points.

Abstract: A method of processing BMGs in a non-ideal environment (such as air) to create a uniform and smooth surface is provided. By utilizing the contact-line movement and an engineered flow pattern during TPF the method is able to create complex BMG parts that exhibit uniform smooth appearance or even can be atomically smooth. In addition, to mending surface imperfections, this method also eliminates void formation inside the material, allows for the creation of precise patterns of homogeneous appearance, and forms improved mechanical locks between different materials and a BMG.

Abstract: The present invention relates to nucleic acid sequences and cellular proteins encoded by these sequences that are involved in infection or are otherwise associated with the life cycle of one or more pathogens.

Abstract: The present invention relates to nucleic acid sequences and cellular proteins encoded by these sequences that are involved in infection or are otherwise associated with the life cycle of one or more pathogens.

Abstract: The present invention relates to cellular proteins that are involved in infection or are otherwise associated with the life cycle of one or more pathogens.

Abstract: The present invention relates to nucleic acid sequences and cellular proteins encoded by these sequences that are involved in infection or are otherwise associated with the life cycle of one or more pathogens.

Abstract: The present invention relates to a protein, ADAM10, ADAM10 nucleic acid sequences and ADAM10 proteins encoded by these sequences that are involved in infection by one or more pathogen such as a virus, a parasite, a bacteria or a fungus or are otherwise associated with the life cycle of a pathogen.

Abstract: The present invention relates to a protein, ADAM10, ADAM10 nucleic acid sequences and ADAM10 proteins encoded by these sequences that are involved in infection by one or more pathogen such as a virus, a parasite, a bacteria or a fungus or are otherwise associated with the life cycle of a pathogen.

Abstract: Disclosed herein are methods of reducing infection of a cell by a pathogen, for example to treat or prevent a pathogen infection. Exemplary pathogens include those that use a lipid raft. The disclosure also relates to methods of identifying agents involved in pathogen infection, such as modulators of Rab9A and Rab11A.

Abstract: The present invention provides inducible promoter systems. In particular, the present invention provides benzoate inducible promoters and promoter systems, and modifications and uses thereof.

Abstract: Host nucleic acids and host proteins that participate in viral infection, such as human immunodeficiency virus (HIV), influenza A, and Ebola virus, have been identified. Interfering with or disrupting the interaction between a host nucleic acid or host protein and a virus or viral protein confers an inhibition of or resistance to infection. Thus, interfering with such an interaction in a host subject can confer a therapeutic or prophylactic effect against a virus. The sequences identified can be used to identify agents that reduce or inhibit viral infection.

Abstract: The present invention relates to crystalline Rab9 in complex with either GDP or the GTP analog Guanosine 5?-(?,?-imido) triphosphate (GppNHp), the three dimensional coordinates and structures of Rab9 in Rab9-GDP and Rab9-GppNHp complexes, and uses thereof for drug design. In particular, the present invention relates to methods for producing Rab9 crystals of sufficient quality to obtain a determination of the three dimensional structure of Rab9 to a high resolution in both its GTP-bound (on/active) and GDP-bound (off/inactive) conformations. The present invention also relates to a computer-readable medium encoded with the three dimensional coordinates of Rab9 in Rab9-GDP and Rab9-GppNHp complexes wherein, using a graphical display software program, the three dimensional coordinates create an electronic file that can be visualized on a computer capable of representing the electronic file as a three dimensional image.